<DOC>
	<DOCNO>NCT01367080</DOCNO>
	<brief_summary>To evaluate pharmacokinetics single oral dose Amitriptyline hydrochloride film-coated tablet 10mg &amp; 25mg</brief_summary>
	<brief_title>A Study Compare Pharmacokinetic Profiles Etravil® Tablet 10mg Etravil® Tablet 25mg</brief_title>
	<detailed_description>Randomized , Single dose , 2-way crossover , Open Study compare pharmacokinetics profile Etravil® ( Amitriptyline Hydrochloride ) Tablet 10mg Etravil® ( Amitriptyline Hydrochloride ) Tablet 25mg single oral administration healthy male volunteer</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Enuresis</mesh_term>
	<mesh_term>Amitriptyline</mesh_term>
	<mesh_term>Amitriptyline , perphenazine drug combination</mesh_term>
	<criteria>healthy adult male within range 19 50 year old time screen one weight 55kg , range IBW 20 % Ideal Body Weight ( IBW ) ( kg ) = { height ( cm ) 100 } *0.9 one understood completely study detailed explanation give , decide volunteer give write informed consent participate study compliance requirement entire protocol . one clinically significant disease liver , kidney , nerve system , respiratory system , endocrine system , blood , tumor , urinary system , cardiovascular system , mental disease medical history one glaucoma one disorder micturition include benign prostatic hyperplasia one gastrointestinal disease gastrointestinal surgical history affect absorption investigational drug . one allergic clinically significant allergic history study drug , component tricyclic antidepressant ( TCA ) one show follow result vital sign : hypotension ( systolic pressure ≤ 100mmHg diastolic pressure ≤ 65mmHg ) hypertension ( systolic pressure ≥ 150mmHg diastolic pressure ≥ 95mmHg ) one drug abuse history one take prescribed drug , herbal agent crude drug within 2 week study drug administration , take overthecounter ( OTC ) drug vitamin ( Investigators determine eligibility consider effect drug safety pharmacokinetic result case inclusion/exclusion criterion satisfy . ) one participate clinical study within 2 month study drug administration one donate whole blood within 2 month component blood within 1 month donate within 1 month treatment one drank Over 21 units/week alcohol ( 1 unit = 10g pure alcohol ) subject would able stop drinking alcohol hospitalization one heavy smoker 10 cigarettes/day within 3 month prior screen subject would able stop smoke hospitalization one beverage contain caffeine , drank alcohol , smoke within 48hrs hospitalization beverage contain grapefruit hospitalization one clinically significant observation consider unsuitable base medical judgment investigator</criteria>
	<gender>Male</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>depression</keyword>
</DOC>